RGAHX
Price
$75.98
Change
-$0.14 (-0.18%)
Updated
Sep 20 closing price
SAGAX
Price
$48.51
Change
-$0.12 (-0.25%)
Updated
Sep 20 closing price
Ad is loading...

RGAHX vs SAGAX

Header iconRGAHX vs SAGAX Comparison
Open Charts RGAHX vs SAGAXBanner chart's image
American Funds Growth Fund of Amer R5E
Price$75.98
Change-$0.14 (-0.18%)
VolumeN/A
CapitalizationN/A
Virtus Zevenbergen Innovative Gr Stk A
Price$48.51
Change-$0.12 (-0.25%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RGAHX vs SAGAX Comparison Chart
Loading...
VS
RGAHX vs. SAGAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAHX is a StrongBuy and SAGAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 290B vs. SAGAX (522M). RGAHX pays higher dividends than SAGAX: RGAHX (0.64) vs SAGAX (0.00). RGAHX was incepted earlier than SAGAX: RGAHX (9 years) vs SAGAX (21 years). RGAHX is a more actively managed with annual turnover of: 31.00 vs. SAGAX (20.00). RGAHX has a lower initial minimum investment than SAGAX: RGAHX (250) vs SAGAX (2500). SAGAX annual gain was more profitable for investors over the last year : 43.78 vs. RGAHX (30.34). SAGAX return over 5 years is better than : 87.30 vs. RGAHX (54.03).
RGAHXSAGAXRGAHX / SAGAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years21 years-
Gain YTD21.86022.59397%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets290B522M55,556%
Annual Yield % from dividends0.640.00-
Returns for 1 year30.3443.7869%
Returns for 3 years0.79-21.58-4%
Returns for 5 years54.0387.3062%
Returns for 10 yearsN/A122.12-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPTA8.760.16
+1.86%
Perpetua Resources Corp
YHGJ1.010.01
+1.01%
Yunhong Green CTI Ltd
ARQT10.150.01
+0.10%
Arcutis Biotherapeutics
MATX134.72-2.46
-1.79%
Matsons
CSGP77.36-1.93
-2.43%
CoStar Group